Last updated: 1 September 2023 at 4:09pm EST

Nassim Usman Net Worth




The estimated Net Worth of Nassim Usman is at least $1.21 Million dollars as of 9 August 2022. Nassim Usman owns over 3,250 units of Catalyst Biosciences Inc stock worth over $12,516 and over the last 9 years he sold CBIO stock worth over $0. In addition, he makes $1,198,860 as President, Chief Executive Officer und Director at Catalyst Biosciences Inc.

Nassim Usman CBIO stock SEC Form 4 insiders trading

Nassim has made over 12 trades of the Catalyst Biosciences Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 3,250 units of CBIO stock worth $1,528 on 9 August 2022.

The largest trade he's ever made was exercising 5,729 units of Catalyst Biosciences Inc stock on 31 January 2019 worth over $26,525. On average, Nassim trades about 1,324 units every 90 days since 2015. As of 9 August 2022 he still owns at least 24,541 units of Catalyst Biosciences Inc stock.

You can see the complete history of Nassim Usman stock trades at the bottom of the page.





Nassim Usman biography

Dr. Nassim Usman Ph.D. serves as President, Chief Executive Officer, Director of the Company. Since the merger, Dr. Usman has served as our President and Chief Executive Officer and as a Class III director. Effective immediately prior to the Annual Meeting, Dr. Usman was reclassified as a Class II director. Dr. Usman is currently a Venture Partner at Morgenthaler Ventures. Prior to joining Morgenthaler in 2005, he was Senior Vice President and Chief Operating Officer at Sirna Therapeutics Inc., which was subsequently acquired by Merck, from 2004 to 2005, and held various R&D positions at both Sirna and Ribozyme Pharmaceuticals, including Vice President of R&D and Chief Scientific Officer, from 1992 to 2004. During his industrial career, Dr. Usman has overseen the entry of several drugs into clinical development, completion of multiple licensing deals with pharmaceutical and biotechnology companies and raised capital in both private and public financings. Prior to moving into the private sector in 1992, Dr. Usman was an NIH Fogarty and NSERC Postdoctoral Fellow and Scientist in the Departments of Biology and Chemistry at the Massachusetts Institute of Technology from 1987 to 1992. He has authored more than 70 scientific articles and is the named inventor in 130 issued patents and patent applications. Dr. Usman serves on the board of directors of Mosaic Biosciences, is a past director of Principia Biopharma, Osprey Pharmaceuticals, Archemix Corporation and atugen AG (now Silence Therapeutics) and served on the science advisory boards of RXi Pharmaceuticals and Noxxon Pharma AG. He received his B.Sc. (Honours) and Ph.D. in Organic Chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in two marketed RNA products (Macugen™ & Onpattro™).

What is the salary of Nassim Usman?

As the President, Chief Executive Officer und Director of Catalyst Biosciences Inc, the total compensation of Nassim Usman at Catalyst Biosciences Inc is $1,198,860. There are no executives at Catalyst Biosciences Inc getting paid more.



How old is Nassim Usman?

Nassim Usman is 60, he's been the President, Chief Executive Officer und Director of Catalyst Biosciences Inc since 2015. There are 7 older and 1 younger executives at Catalyst Biosciences Inc. The oldest executive at Catalyst Biosciences Inc is Dr. Howard Levy M.B.B.Ch., M.M.M., Ph.D., 67, who is the Consultant.

What's Nassim Usman's mailing address?

Nassim's mailing address filed with the SEC is 260 Littlefield Ave, South San Francisco, CA 94080, USA.

Insiders trading at Catalyst Biosciences Inc

Over the last 9 years, insiders at Catalyst Biosciences Inc have traded over $2,614,728 worth of Catalyst Biosciences Inc stock and bought 81,771 units worth $199,380 . The most active insiders traders include Jeff Himawan, James E Deerfield Mgmt L.P.... und Augustine Lawlor. On average, Catalyst Biosciences Inc executives and independent directors trade stock every 62 days with the average trade being worth of $3,315. The most recent stock trade was executed by Nassim Usman on 9 August 2022, trading 3,250 units of CBIO stock currently worth $1,528.



What does Catalyst Biosciences Inc do?

catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.



What does Catalyst Biosciences Inc's logo look like?

Catalyst Biosciences Inc logo

Complete history of Nassim Usman stock trades at Catalyst Biosciences Inc

Datum
#
Unternehmen
Insider
Trans.
Transaktion
Anzahl der Aktien Preis je Aktie Gesamtpreis Anzahl der Aktien nach Quelle
9 Aug 2022 Nassim Usman
Präsident und CEO
Kauf 3,250 $0.47 $1,528
9 Aug 2022
24,541
9 Feb 2022 Nassim Usman
Präsident und CEO
Kauf 3,250 $0.46 $1,495
9 Feb 2022
21,291
9 Aug 2021 Nassim Usman
Präsident und CEO
Kauf 867 $3.62 $3,139
9 Aug 2021
18,041
5 Apr 2021 Nassim Usman
Präsident und CEO
Optionausübung 5,000 $4.63 $23,150
5 Apr 2021
17,174
9 Feb 2021 Nassim Usman
Präsident und CEO
Kauf 582 $4.81 $2,799
9 Feb 2021
12,174
10 Aug 2020 Nassim Usman
Präsident und CEO
Kauf 582 $4.81 $2,799
10 Aug 2020
11,592
13 Mar 2020 Nassim Usman
Präsident und CEO
Kauf 4,000 $3.91 $15,640
13 Mar 2020
11,010
21 May 2019 Nassim Usman
Präsident und CEO
Optionausübung 4,400 $4.63 $20,372
21 May 2019
10,567
31 Jan 2019 Nassim Usman
Präsident und CEO
Optionausübung 5,729 $4.63 $26,525
31 Jan 2019
11,041
4 Apr 2018 Nassim Usman
Präsident und CEO
Optionausübung 88 $4.63 $407
4 Apr 2018
88
17 Dec 2015 Nassim Usman
Präsident und CEO
Kauf 4,000 $2.00 $8,000
17 Dec 2015
78,375
17 Dec 2015 Nassim Usman
Präsident und CEO
Kauf 4,000 $2.00 $8,000
17 Dec 2015
78,375


Catalyst Biosciences Inc executives and stock owners

Catalyst Biosciences Inc executives and other stock owners filed with the SEC include: